Kenneth J. Hillan - Jun 1, 2022 Form 4 Insider Report for 23andMe Holding Co. (ME)

Role
Chief Therapeutics Officer
Signature
/s/ Kenneth Hillan, by Kathy Hibbs, attorney-in-fact
Stock symbol
ME
Transactions as of
Jun 1, 2022
Transactions value $
-$13,048
Form type
4
Date filed
6/2/2022, 04:26 PM
Previous filing
Mar 1, 2022
Next filing
Aug 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ME Class A Common Stock Tax liability -$13K -4.63K -2.16% $2.82 209K Jun 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The closing price on June 1, 2022, the transaction date.